HU227742B1
(en)
*
|
1996-10-18 |
2012-02-28 |
Vertex Pharma |
Inhibitors of serine proteases, particularly hepatitis c virus ns3 protease
|
JP2001508767A
(ja)
*
|
1996-12-02 |
2001-07-03 |
藤沢薬品工業株式会社 |
5―ht拮抗作用を有するインドール―ウレア誘導体
|
EP1366766A1
(en)
*
|
1997-03-14 |
2003-12-03 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme
|
US6093742A
(en)
*
|
1997-06-27 |
2000-07-25 |
Vertex Pharmaceuticals, Inc. |
Inhibitors of p38
|
PL340261A1
(en)
|
1997-10-31 |
2001-01-29 |
Aventis Pharma Ltd |
Substituted amilides
|
DE1043995T1
(de)
*
|
1997-12-22 |
2001-06-07 |
Bayer Corp., Pittsburgh |
INHIBIERUNG DER p38 KINASE-AKTIVITÄT DURCH DIE VERWENDUNG VON ARYL- UND HETEROARYLSUBSTITUIERTEN HARNSTOFFEN
|
AU2198999A
(en)
*
|
1997-12-22 |
1999-07-12 |
Bayer Corporation |
Inhibition of raf kinase using substituted heterocyclic ureas
|
EP1076641A1
(en)
*
|
1998-04-29 |
2001-02-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of impdh enzyme
|
EP1085010B1
(en)
*
|
1998-06-04 |
2004-03-10 |
Kumiai Chemical Industry Co., Ltd. |
Phenylacetylene derivatives and agricultural/horticultural bactericides
|
BR9914638A
(pt)
*
|
1998-10-22 |
2001-07-03 |
Neurosearch As |
Composto, método para a preparação do mesmo, composição farmacêutica, uso de um composto, e, método para o tratamento de um distúrbio ou doença de um corpo de animal vivo
|
WO2000026197A1
(en)
|
1998-10-29 |
2000-05-11 |
Bristol-Myers Squibb Company |
Novel inhibitors of impdh enzyme
|
US6596747B2
(en)
|
1998-10-29 |
2003-07-22 |
Bristol-Myers Squibb Company |
Compounds derived from an amine nucleus and pharmaceutical compositions comprising same
|
US6420403B1
(en)
|
1998-10-29 |
2002-07-16 |
Edwin J. Iwanowicz |
Inhibitors of IMPDH enzyme
|
CA2348234A1
(en)
|
1998-10-29 |
2000-05-11 |
Chunjian Liu |
Compounds derived from an amine nucleus that are inhibitors of impdh enzyme
|
GB9823873D0
(en)
|
1998-10-30 |
1998-12-30 |
Pharmacia & Upjohn Spa |
2-ureido-thiazole derivatives,process for their preparation,and their use as antitumour agents
|
CN1332725A
(zh)
*
|
1998-12-09 |
2002-01-23 |
美国家庭用品有限公司 |
疱疹病毒的硫脲抑制剂
|
US6201013B1
(en)
|
1998-12-09 |
2001-03-13 |
American Home Products Corporation |
Heterocyclic carboxamide-containing thiourea inhibitors of herpes viruses containing a substituted phenylenediamine group
|
DK1137645T3
(da)
*
|
1998-12-09 |
2004-08-09 |
Wyeth Corp |
Alfa-methylbenzylholdige thiourinstofinhibitorer af herpesvira indeholdende en phenylendiamingruppe
|
US6262090B1
(en)
|
1998-12-09 |
2001-07-17 |
American Home Products Corporation |
Aminopyridine-containing thiourea inhibitors of herpes viruses
|
US6166028A
(en)
|
1998-12-09 |
2000-12-26 |
American Home Products Corporation |
Diaminopuridine-containing thiourea inhibitors of herpes viruses
|
US6337338B1
(en)
|
1998-12-15 |
2002-01-08 |
Telik, Inc. |
Heteroaryl-aryl ureas as IGF-1 receptor antagonists
|
EP1142868A4
(en)
*
|
1998-12-22 |
2004-09-29 |
Mitsubishi Chem Corp |
amide derivatives
|
EP1158985B1
(en)
|
1999-01-13 |
2011-12-28 |
Bayer HealthCare LLC |
OMEGA-CARBOXY ARYL SUBSTITUTED DIPHENYL UREAS AS p38 KINASE INHIBITORS
|
US8124630B2
(en)
|
1999-01-13 |
2012-02-28 |
Bayer Healthcare Llc |
ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
|
US7928239B2
(en)
|
1999-01-13 |
2011-04-19 |
Bayer Healthcare Llc |
Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas
|
ATE278674T1
(de)
*
|
1999-03-12 |
2004-10-15 |
Boehringer Ingelheim Pharma |
Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
|
ES2405316T3
(es)
|
1999-03-19 |
2013-05-30 |
Vertex Pharmaceuticals Incorporated |
Inhibidores de la enzima IMPDH
|
US6653309B1
(en)
|
1999-04-26 |
2003-11-25 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of IMPDH enzyme technical field of the invention
|
AU5031200A
(en)
*
|
1999-05-28 |
2000-12-18 |
Vertex Pharmaceuticals Incorporated |
Method for preparing 5-substituted oxazoles
|
US6107052A
(en)
*
|
1999-06-09 |
2000-08-22 |
Roche Diagnostics Corporation |
Enzymatic measurement of mycophenolic acid
|
ATE248835T1
(de)
*
|
1999-06-25 |
2003-09-15 |
Vertex Pharma |
Prodrugs von impdh-inhibierenden carbamaten
|
JP2001011060A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
新規オキサゾール化合物及びその製造方法
|
JP2001011059A
(ja)
*
|
1999-06-28 |
2001-01-16 |
Nippon Synthetic Chem Ind Co Ltd:The |
5−(2−置換−4−ニトロフェニル)−オキサゾールの製造方法
|
TWI262185B
(en)
*
|
1999-10-01 |
2006-09-21 |
Eisai Co Ltd |
Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
|
US6867299B2
(en)
|
2000-02-24 |
2005-03-15 |
Hoffmann-La Roche Inc. |
Oxamide IMPDH inhibitors
|
JP2003531205A
(ja)
|
2000-04-24 |
2003-10-21 |
ブリストル−マイヤーズ スクイブ カンパニー |
Impdh酵素の阻害剤である複素環化合物
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
US6423849B1
(en)
|
2000-09-01 |
2002-07-23 |
The Nippon Synthetic Chemical Industry Co., Ltd. |
Process of preparing 5-(2-substituted-4-nitrophenyl)-oxazole, novel oxazole compound, and process of preparing the same
|
US6593362B2
(en)
*
|
2001-05-21 |
2003-07-15 |
Guilford Pharmaceuticals Inc. |
Non-peptidic cyclophilin binding compounds and their use
|
TW200301698A
(en)
|
2001-12-21 |
2003-07-16 |
Bristol Myers Squibb Co |
Acridone inhibitors of IMPDH enzyme
|
AU2003209118A1
(en)
|
2002-02-11 |
2003-09-04 |
Bayer Pharmaceuticals Corporation |
Aryl ureas as kinase inhibitors
|
EP1478358B1
(en)
|
2002-02-11 |
2013-07-03 |
Bayer HealthCare LLC |
Sorafenib tosylate for the treatment of diseases characterized by abnormal angiogenesis
|
EP1402887A1
(en)
*
|
2002-09-18 |
2004-03-31 |
Jerini AG |
New compounds for the inhibition of undesired cell proliferation and use thereof
|
AU2003298868B2
(en)
*
|
2002-12-06 |
2009-09-17 |
Vertex Pharmaceuticals Incorporated |
Compositions comprising a combination of diphenyl ura IMPDH inhibitors and apoptosis-inducing anti-cancer agents
|
ATE457716T1
(de)
|
2002-12-30 |
2010-03-15 |
Angiotech Int Ag |
Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
|
US7220768B2
(en)
*
|
2003-02-11 |
2007-05-22 |
Wyeth Holdings Corp. |
Isoxazole-containing thiourea inhibitors useful for treatment of varicella zoster virus
|
CA2526636C
(en)
|
2003-05-20 |
2012-10-02 |
Bayer Pharmaceuticals Corporation |
Diaryl ureas for diseases mediated by pdgfr
|
CL2004001834A1
(es)
|
2003-07-23 |
2005-06-03 |
Bayer Pharmaceuticals Corp |
Compuesto 4-{4-[3-(4-cloro-3-trifluorometilfenil)-ureido]-3-fluorofenoxi}-piridin-2-metilamida, inhibidor de la raf, vegfr, p38 y pdgfr quinasas, sus sales; composiicon farmaceutica; combinacion farmaceutica; y su uso para tratar trastornos hiperprol
|
UY28500A1
(es)
*
|
2003-09-05 |
2005-04-29 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc.
|
EP1692157B1
(en)
|
2003-10-10 |
2013-04-17 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
AR045870A1
(es)
*
|
2003-10-11 |
2005-11-16 |
Vertex Pharma |
Terapia de combinacion para la infeccion de virus de hepatitis c
|
CN1894276B
(zh)
|
2003-10-27 |
2010-06-16 |
威特克斯医药股份有限公司 |
Hcv ns3-ns4a蛋白酶抗药性突变体
|
EP1944042A1
(en)
|
2003-10-27 |
2008-07-16 |
Vertex Pharmceuticals Incorporated |
Combinations for HCV treatment
|
JP2008505849A
(ja)
|
2004-02-04 |
2008-02-28 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
セリンプロテアーゼ、特に、hcv、ns3−ns4aプロテアーゼの阻害剤
|
US7317030B2
(en)
|
2004-02-26 |
2008-01-08 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
EP1568696A1
(en)
*
|
2004-02-26 |
2005-08-31 |
4Sc Ag |
Compounds as inhibitors of cell proliferation and viral infections
|
CA2571710A1
(en)
|
2004-06-24 |
2006-11-02 |
Nicholas Valiante |
Small molecule immunopotentiators and assays for their detection
|
AP2326A
(en)
|
2004-08-12 |
2011-11-24 |
Pfizer |
Triazolopyridinylsulfanyl derivatives as p38 map kinase inhibitors.
|
CA2583472A1
(en)
|
2004-10-01 |
2006-04-13 |
Chao Lin |
Hcv ns3-ns4a protease inhibition
|
TW201424733A
(zh)
|
2004-10-29 |
2014-07-01 |
Vertex Pharma |
劑量型式
|
US7625931B2
(en)
*
|
2005-01-14 |
2009-12-01 |
Cgi Pharmaceuticals, Inc. |
Certain substituted diphenyl ureas, as modulators of kinase activity
|
EP2397478A1
(en)
*
|
2005-01-14 |
2011-12-21 |
CGI Pharmaceuticals, Inc. |
1,3-diaryl substituted ureas as modulators of kinase activity.
|
US20060235009A1
(en)
*
|
2005-02-08 |
2006-10-19 |
Richard Glickman |
Treatment of vascular, autoimmune and inflammatory diseases using low dosages of IMPDH inhibitors
|
WO2006086500A2
(en)
*
|
2005-02-08 |
2006-08-17 |
Aspreva Pharmaceuticals Sa |
Compositions and methods for treating vascular, autoimmune and inflammatory diseases
|
UA93673C2
(ru)
|
2005-03-07 |
2011-03-10 |
Баер Шеринг Фарма Акциенгезельшафт |
Фармацевтическая композиция, которая содержит омега-карбоксиарилзамещенную дифенилмочевину, для лечения paka
|
US7777040B2
(en)
*
|
2005-05-03 |
2010-08-17 |
Cgi Pharmaceuticals, Inc. |
Certain substituted ureas, as modulators of kinase activity
|
JP2008540538A
(ja)
*
|
2005-05-09 |
2008-11-20 |
バーテックス ファーマシューティカルズ インコーポレイテッド |
(s)−3−(3−(3−メトキシ−4−(オキサゾール−5−イル)フェニル)ウレイド)ベンジルカルバミン酸テトラヒドロフラン−3−イルの多形形態
|
EP1879858A2
(en)
|
2005-05-09 |
2008-01-23 |
Vertex Pharmaceuticals, Inc. |
Processes for preparing biaryl ureas and analogs thereof
|
JO2768B1
(en)
|
2005-07-29 |
2014-03-15 |
تيبوتيك فارماسيوتيكالز ليمتد |
Large cyclic inhibitors of hepatitis C virus
|
CA2617096C
(en)
|
2005-07-29 |
2013-12-24 |
Tibotec Pharmaceuticals Ltd. |
Macrocyclic inhibitors of hepatitis c virus
|
PE20070211A1
(es)
|
2005-07-29 |
2007-05-12 |
Medivir Ab |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
TWI383980B
(zh)
|
2005-07-29 |
2013-02-01 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑
|
PE20070210A1
(es)
|
2005-07-29 |
2007-04-16 |
Tibotec Pharm Ltd |
Compuestos macrociclicos como inhibidores del virus de hepatitis c
|
MY142972A
(en)
|
2005-07-29 |
2011-01-31 |
Tibotec Pharm Ltd |
Macrocyclic inhibitors of hepatitis c virus
|
TWI393723B
(zh)
|
2005-07-29 |
2013-04-21 |
Tibotec Pharm Ltd |
C型肝炎病毒之大環抑制劑(九)
|
ES2373685T3
(es)
|
2005-07-29 |
2012-02-07 |
Tibotec Pharmaceuticals |
Inhibidores macrocíclicos del virus de la hepatitis c.
|
BRPI0614620A2
(pt)
|
2005-07-29 |
2011-04-12 |
Tibotec Pharm Ltd |
compostos inibidores macrocìclicos do vìrus da hepatite c, uso dos mesmos, processo para preparar os referidos compostos, combinação e composição farmacêutica
|
CN101277950B
(zh)
*
|
2005-08-02 |
2013-03-27 |
弗特克斯药品有限公司 |
丝氨酸蛋白酶抑制剂
|
AR055395A1
(es)
*
|
2005-08-26 |
2007-08-22 |
Vertex Pharma |
Compuestos inhibidores de la actividad de la serina proteasa ns3-ns4a del virus de la hepatitis c
|
US7964624B1
(en)
*
|
2005-08-26 |
2011-06-21 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases
|
US7705138B2
(en)
|
2005-11-11 |
2010-04-27 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP2392590A3
(en)
|
2005-11-11 |
2012-03-14 |
Vertex Pharmaceuticals Incorporated |
Hepatitis C virus variants
|
EP1991229A2
(en)
|
2006-02-27 |
2008-11-19 |
Vertex Pharmaceuticals Incorporated |
Co-crystals and pharmaceutical compositions comprising the same
|
MX2008011868A
(es)
|
2006-03-16 |
2008-12-15 |
Vertex Pharma |
Inhibidores deuterados de la proteasa de la hepatitis c.
|
NZ571826A
(en)
|
2006-04-11 |
2012-01-12 |
Novartis Ag |
HCV/HIV inhibitors and their uses
|
US20080076770A1
(en)
*
|
2006-09-25 |
2008-03-27 |
Arete Therapeutics, Inc. |
Soluble epoxide hydrolase inhibitors
|
JP5616063B2
(ja)
|
2006-10-04 |
2014-10-29 |
ヤンセン・アールアンドデイ・アイルランド |
Hcv阻害剤として有用なカルボキシアミド4−[(4−ピリジル)アミノ]ピリミジン
|
CA2661338C
(en)
|
2006-11-17 |
2015-05-12 |
Tibotec Pharmaceuticals Ltd. |
Macrocyclic inhibitors of hepatitis c virus
|
CA2679426A1
(en)
*
|
2007-02-27 |
2008-09-04 |
Luc Farmer |
Inhibitors of serine proteases
|
EP2463285A1
(en)
*
|
2007-02-27 |
2012-06-13 |
Vertex Pharmaceuticals Inc. |
Co-crystals and pharmaceutical compositions comprising the same
|
WO2008131253A1
(en)
*
|
2007-04-20 |
2008-10-30 |
Deciphera Pharmaceuticals, Llc |
Kinase inhibitors useful for the treatment of myleoproliferative diseases and other proliferative diseases
|
ATE548044T1
(de)
|
2007-05-04 |
2012-03-15 |
Vertex Pharma |
Kombinationstherapie zur behandlung von hiv- infektionen
|
MX2010002407A
(es)
*
|
2007-08-30 |
2010-03-26 |
Vertex Pharma |
Cocristales y composiciones farmaceuticas que los comprenden.
|
ES2389994T3
(es)
|
2007-12-24 |
2012-11-05 |
Janssen R&D Ireland |
Indoles macrocíclicos como inhibidores del virus de la hepatitis C
|
TWI454476B
(zh)
|
2008-07-08 |
2014-10-01 |
Tibotec Pharm Ltd |
用作c型肝炎病毒抑制劑之巨環吲哚衍生物
|
EP2331554B1
(en)
|
2008-08-14 |
2013-03-06 |
Janssen R&D Ireland |
Macrocyclic indole derivatives useful as hepatitis c virus inhibitors
|
PT2373172E
(pt)
|
2008-12-03 |
2013-10-21 |
Presidio Pharmaceuticals Inc |
Inibidores de ns5a de hcv
|
BRPI0922364A2
(pt)
|
2008-12-03 |
2017-08-29 |
Presidio Pharmaceuticals Inc |
Composto, composição farmacêutica e uso de um composto
|
EP2396028A2
(en)
|
2009-02-12 |
2011-12-21 |
Vertex Pharmceuticals Incorporated |
Hcv combination therapies comprising pegylated interferon, ribavirin and telaprevir
|
EP2408753A4
(en)
*
|
2009-03-20 |
2012-11-07 |
Univ Brandeis |
COMPOUNDS AND METHOD FOR THE TREATMENT OF MICROBIAL STOMACH DARM INFECTIONS IN MAMMALS
|
US9150554B2
(en)
|
2009-03-27 |
2015-10-06 |
Presidio Pharmaceuticals, Inc. |
Fused ring inhibitors of hepatitis C
|
US20110182850A1
(en)
|
2009-04-10 |
2011-07-28 |
Trixi Brandl |
Organic compounds and their uses
|
US8512690B2
(en)
|
2009-04-10 |
2013-08-20 |
Novartis Ag |
Derivatised proline containing peptide compounds as protease inhibitors
|
US20110027229A1
(en)
|
2009-07-31 |
2011-02-03 |
Medtronic, Inc. |
Continuous subcutaneous administration of interferon-alpha to hepatitis c infected patients
|
UA108211C2
(uk)
|
2009-11-04 |
2015-04-10 |
Янссен Рід Айрленд |
Бензімідазолімідазольні похідні
|
AU2011210795A1
(en)
|
2010-01-29 |
2012-08-02 |
Vertex Pharmaceuticals Incorporated |
Therapies for treating Hepatitis C virus infection
|
WO2011112516A1
(en)
|
2010-03-08 |
2011-09-15 |
Ico Therapeutics Inc. |
Treating and preventing hepatitis c virus infection using c-raf kinase antisense oligonucleotides
|
US8877707B2
(en)
|
2010-05-24 |
2014-11-04 |
Presidio Pharmaceuticals, Inc. |
Inhibitors of HCV NS5A
|
MX2020004501A
(es)
|
2010-06-03 |
2021-11-09 |
Pharmacyclics Llc |
El uso de inhibidores de la tirosina quinasa de bruton (btk).
|
WO2011156545A1
(en)
|
2010-06-09 |
2011-12-15 |
Vertex Pharmaceuticals Incorporated |
Viral dynamic model for hcv combination therapy
|
JP5870098B2
(ja)
|
2010-06-24 |
2016-02-24 |
ヤンセン・サイエンシズ・アイルランド・ユーシー |
13−シクロヘキシル−3−メトキシ−6−[メチル−(2−{2−[メチル−(スルファモイル)−アミノ]−エトキシ}−エチル)−カルバモイル]−7H−インドロ−[2,1−a]−[2]−ベンズアゼピン−10−カルボン酸の製造
|
WO2012009503A1
(en)
|
2010-07-14 |
2012-01-19 |
Vertex Pharmaceuticals Incorporated |
Palatable pharmaceutical composition comprising vx-950
|
AR082619A1
(es)
|
2010-08-13 |
2012-12-19 |
Hoffmann La Roche |
Inhibidores del virus de la hepatitis c
|
WO2012109646A1
(en)
|
2011-02-11 |
2012-08-16 |
Vertex Pharmaceuticals Incorporated |
Treatment of hcv in hiv infection patients
|
CN102985104A
(zh)
|
2011-02-25 |
2013-03-20 |
麦德托尼克公司 |
在干扰素-α治疗方案中使用药代动力学分布和药效动力学分布的方法和系统
|
WO2012123298A1
(en)
|
2011-03-11 |
2012-09-20 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
BR112013032188A2
(pt)
|
2011-06-23 |
2016-12-20 |
Digna Biotech Sl |
composição, produto e método para tratar pacientes com hepatite c crônica
|
WO2012175581A1
(en)
|
2011-06-24 |
2012-12-27 |
F. Hoffmann-La Roche Ag |
Antiviral compounds
|
US9180193B2
(en)
|
2011-10-10 |
2015-11-10 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
WO2013087743A1
(en)
|
2011-12-16 |
2013-06-20 |
F. Hoffmann-La Roche Ag |
Inhibitors of hcv ns5a
|
US9708357B2
(en)
|
2011-12-20 |
2017-07-18 |
Riboscience, LLC |
4′-azido, 3′-fluoro substituted nucleoside derivatives as inhibitors of HCV RNA replication
|
JP5982007B2
(ja)
|
2011-12-20 |
2016-08-31 |
リボサイエンス・エルエルシー |
Hcvrna複製の阻害薬としての2’,4’−ジフルオロ−2’−メチル置換されたヌクレオシド誘導体
|
BR112014016157A8
(pt)
|
2011-12-28 |
2017-07-04 |
Janssen R&D Ireland |
derivados heterobicíclicos como inibidores de vhc
|
US20130195797A1
(en)
|
2012-01-31 |
2013-08-01 |
Vertex Pharmaceuticals Incorporated |
High potency formulations of vx-950
|
RU2014137052A
(ru)
|
2012-02-24 |
2016-04-10 |
Ф.Хоффманн-Ля Рош Аг |
Противовирусные соединения
|
US8461179B1
(en)
|
2012-06-07 |
2013-06-11 |
Deciphera Pharmaceuticals, Llc |
Dihydronaphthyridines and related compounds useful as kinase inhibitors for the treatment of proliferative diseases
|
US20140010783A1
(en)
|
2012-07-06 |
2014-01-09 |
Hoffmann-La Roche Inc. |
Antiviral compounds
|
KR20180088926A
(ko)
|
2012-07-24 |
2018-08-07 |
파마싸이클릭스 엘엘씨 |
브루톤 티로신 키나제(btk)의 억제제에 대한 내성과 관련된 돌연변이
|
WO2014028931A2
(en)
|
2012-08-17 |
2014-02-20 |
Brandeis University |
Compounds and methods for treating mammalian gastrointestinal microbial infections
|
US20140205566A1
(en)
|
2012-11-30 |
2014-07-24 |
Novartis Ag |
Cyclic nucleuoside derivatives and uses thereof
|
JP6096324B2
(ja)
|
2013-01-23 |
2017-03-15 |
エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft |
抗ウイルス性トリアゾール誘導体
|
KR20150114566A
(ko)
|
2013-03-05 |
2015-10-12 |
에프. 호프만-라 로슈 아게 |
항바이러스 화합물
|
AU2014265293B2
(en)
|
2013-05-16 |
2019-07-18 |
Riboscience Llc |
4'-Fluoro-2'-methyl substituted nucleoside derivatives
|
SG11201509427RA
(en)
|
2013-05-16 |
2015-12-30 |
Riboscience Llc |
4'-azido, 3'-deoxy-3'-fluoro substituted nucleoside derivatives
|
US20180200280A1
(en)
|
2013-05-16 |
2018-07-19 |
Riboscience Llc |
4'-Fluoro-2'-Methyl Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication
|
EA201690746A1
(ru)
|
2013-10-25 |
2016-12-30 |
Фармасайкликс Элэлси |
Лечение с применением ингибиторов тирозинкиназы брутона и иммунотерапии
|
US9885086B2
(en)
|
2014-03-20 |
2018-02-06 |
Pharmacyclics Llc |
Phospholipase C gamma 2 and resistance associated mutations
|
EP3684374A4
(en)
|
2017-09-21 |
2021-06-16 |
Riboscience LLC |
4'-FLUORO-2'-METHYL SUBSTITUTE NUCLEOSIDE DERIVATIVES USED AS HCV RNA REPLICATION INHIBITORS
|
SG11202007198WA
(en)
|
2018-01-31 |
2020-08-28 |
Deciphera Pharmaceuticals Llc |
Combination therapy for the treatment of gastrointestinal stromal tumors
|
WO2019191032A1
(en)
|
2018-03-26 |
2019-10-03 |
Clear Creek Bio, Inc. |
Compositions and methods for inhibiting dihydroorotate dehydrogenase
|
CN109970675A
(zh)
*
|
2018-05-28 |
2019-07-05 |
中国医学科学院医药生物技术研究所 |
一组硫脲化合物及其制备方法和应用
|
WO2019244047A1
(en)
|
2018-06-19 |
2019-12-26 |
Novartis Ag |
N-substituted tetrahydrothienopyridine derivatives and uses thereof
|
BR112022002609A2
(pt)
|
2019-08-12 |
2022-08-09 |
Deciphera Pharmaceuticals Llc |
Métodos de tratamento de tumores estromais gastrointestinais
|
WO2021030405A1
(en)
|
2019-08-12 |
2021-02-18 |
Deciphera Pharmaceuticals, Llc |
Ripretinib for treating gastrointestinal stromal tumors
|
CN110590535A
(zh)
*
|
2019-10-12 |
2019-12-20 |
重庆医药高等专科学校 |
用二氧化硒氧化芳香乙酮制备芳香乙醛酸的方法
|
KR20220123058A
(ko)
|
2019-12-30 |
2022-09-05 |
데시페라 파마슈티칼스, 엘엘씨. |
1-(4-브로모-5-(1-에틸-7-(메틸아미노)-2-옥소-1,2-디히드로-1,6-나프티리딘-3-일)-2-플루오로페닐)-3-페닐우레아의 조성물
|
DK4084778T3
(da)
|
2019-12-30 |
2023-12-11 |
Deciphera Pharmaceuticals Llc |
Amorfe kinaseinhibitorformuleringer og fremgangsmåder til anvendelse deraf
|
US20210315880A1
(en)
|
2020-03-20 |
2021-10-14 |
Clear Creek Bio, Inc. |
Methods of treating viral infections using inhibitors of nucleotide synthesis pathways
|
WO2021209563A1
(en)
|
2020-04-16 |
2021-10-21 |
Som Innovation Biotech, S.A. |
Compounds for use in the treatment of viral infections by respiratory syndrome-related coronavirus
|
US11779572B1
(en)
|
2022-09-02 |
2023-10-10 |
Deciphera Pharmaceuticals, Llc |
Methods of treating gastrointestinal stromal tumors
|